Erica Fiorini Sep 24 Peking University and Qingdi Quantum Achieve Major Progress in Single-Cell Adhesion Dynamics by Erica Fiorini | September 24, 2026 396 Researchers at the Peking University School of Life Sciences (Qin Siying's group), working with Qingdi Quantum Scientific Instruments (Beijing) Co., Ltd., published a study in the Chinese core journal... Read more > Case Studies Sep 24, 2026 Case Studies
Erica Fiorini Aug 25 The Same-Cell, Four Different Cities by Erica Fiorini | August 25, 2026 623 Traditional high-dimensional molecular profiling in biology hits the same wall: to measure a cell, you have to kill it, so you never see what it would have become. In genome engineering, most delivery... Read more > Case Studies FluidFM Applications Aug 25, 2026 Case Studies
Erica Fiorini Jul 20 Cytosurge elects veteran biotech executive, investor, and company builder Luba Greenwood, J.D., to its Board of Directors by Erica Fiorini | July 20, 2026 965 ZURICH, Switzerland – July 20, 2026 - Cytosurge, the pioneer of Same-Cell Biology, announces the election of Luba Greenwood, J.D. , to its Board of Directors, effective July 9, 2026. Greenwood is a di... Read more > Press Release Jul 20, 2026
Erica Fiorini Jul 09 Cytosurge’s CellEDIT Conquers "Impossible" Genome Engineering Challenges by Erica Fiorini | July 9, 2026 1239 Zurich, Switzerland – July 9, 2026 – Cytosurge AG, the pioneer of same-cell biology, announced today the open-access publication of a collaborative study with the Technical University of Denmark (DTU)... Read more > Press Release Jul 9, 2026
Erica Fiorini May 12 Advancing Hedgehog Signaling Research Through Synthetic Biology by Erica Fiorini | May 12, 2026 1049 Dr. Shixin Ye-Lehmann , Principal Investigator at INSERM U1195 (Diseases and Hormones of the Nervous System), Hôpital de Bicêtre, University Paris-Saclay, pioneers synthetic biology tools to address n... Read more > Case Studies May 12, 2026 Case Studies
Erica Fiorini Feb 03 Laying the Foundation: How a Complex Edit Unlocked a New Research Direction by Erica Fiorini | February 3, 2026 2794 The Human Embryonic Kidney 293T (HEK293T) cell line is a research staple, but for Dr. Marta Popović at the Ruđer Bošković Institute , it represented a critical bottleneck. Her lab was launching a stra... Read more > Case Studies Feb 3, 2026 Case Studies
Erica Fiorini Dec 15 Accelerating Adoptive Cell Therapy Development by Erica Fiorini | December 15, 2025 2140 Today, we feature Dr. Alessandro Penna from the University of Padova, whose research focuses on advancing adoptive cell therapies for prostate cancer. When standard gene-editing protocols failed to pr... Read more > Case Studies Dec 15, 2025 Case Studies
Erica Fiorini Sep 24 Cytosurge and Lexogen Announce First End-to-End Commercial Live-Cell Sequencing Workflow by Erica Fiorini | September 24, 2025 3013 Zürich, Switzerland, and Vienna, Austria – Sept. 24, 2025 – Cytosurge AG, a leader in single-cell manipulation technologies, and Lexogen, a pioneer in RNA sequencing solutions, today announced that th... Read more > Press Release Sep 24, 2025
Erica Fiorini Aug 04 Advancing Single-Cell Research by Erica Fiorini | August 4, 2025 2502 We recently had the opportunity to speak with two remarkable professionals from Institut Curie , France's leading cancer research center. Dr. Leanne de Koning, Project Manager of the Single Cell Initi... Read more > Case Studies FluidFM Applications Aug 4, 2025 Case Studies
Erica Fiorini Jul 21 Zhejiang University Landmark Discovery by Erica Fiorini | July 21, 2025 2528 Cancer immunotherapy has emerged as an effective strategy in oncology treatment. However, achieving localized, persistent immune stimulation at tumor sites while effectively counteracting the immunosu... Read more > Case Studies Jul 21, 2025 Case Studies
Erica Fiorini Jun 16 Turning CRISPR Challenges into Breakthroughs by Erica Fiorini | June 16, 2025 3478 Today, we are pleased to introduce Dr. Alfonso Calvo , a principal investigator at Cancer Center Clínica Universidad de Navarra (CCUN) in Spain. His research focuses on understanding how changes in th... Read more > Case Studies FluidFM Applications Jun 16, 2025 Case Studies
Erica Fiorini Apr 09 Cytosurge Appoints Magid Haddouchi as Chief Commercial Officer by Erica Fiorini | April 9, 2025 5194 Zurich, Switzerland – April 9, 2025 – Cytosurge AG, a leading biotech company in single-cell manipulation and cell engineering solutions, announces the appointment of Magid Haddouchi, as its new Chief... Read more > Press Release Apr 9, 2025
